Showing results (101-110 of 143) with videos related to
Sort By:
Pageof 15
American Journal of Hematology|September 6, 2023
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panelFarhad Ravandi, Jacqueline Cloos, Francesco Buccisano, et al.Journal of Clinical Medicine|April 12, 2022
In <i>BCR-ABL1</i> Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces HypofibrinogenemiaElisa Buzzatti, Fabio Forghieri, Giovangiacinto Paterno, et al.Leukemia|June 22, 2023
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patientsGianfranco Catalano, Alessandra Zaza, Cristina Banella, et al.Haematologica|October 14, 2011
CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling studyGiovanni Del Poeta, Maria Ilaria Del Principe, Antonella Zucchetto, et al.The Lancet. Oncology|September 26, 2015
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort studyFabio Efficace, Gianluca Gaidano, Massimo Breccia, et al.Annals of Hematology|April 20, 2016
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter studyFrancesco Buccisano, Anna Lina Piccioni, Carolina Nobile, et al.European Journal of Haematology|May 29, 2015
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemiaMaria Teresa Voso, Pasquale Niscola, Alfonso Piciocchi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trialMonia Marchetti, Giovanni Barosi, Francesca Balestri, et al.Cancers|April 3, 2021
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric ObservationFrancesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 18, 2002
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumorsAntonio Bruno, Tommaso Caravita, Gaspare Adorno, et al.Pageof 15